Association of iron therapy with incidence of chronic kidney disease.

Prabin ShresthaShejuti PaulKeiichi SumidaFridtjof ThomasSatya SurbhiAbu Mohd NaserElani StrejaConnie M RheeKamyar Kalantar-ZadehCsaba Pal Kovesdy

Published in: European journal of haematology (2023)

Oral iron replacement is associated with higher risk of new onset CKD. The long-term kidney safety of oral iron replacement should be tested in clinical trials.

Keyphrases

chronic kidney disease
clinical trial
end stage renal disease
iron deficiency
risk factors
randomized controlled trial
open label
mesenchymal stem cells
phase ii